Latest

SPECIAL REPORT 25.09 Roche and Alzheimer’s disease On July 28, at the Alzheimer’s Association International Conference (AAIC) held in Toronto (Canada), Roche presented new data from its development portfolio including additional diagnostics outcomes. In several oral presentations Roche disclosed its latest results from the ongoing trontinemab’s

SPECIAL REPORT 25.5 Scientific publication This article was published in a different format in the April issue of MedNous Learn more The development of new drugs is dependent on many factors, and one of the most important is being able to identify and reach a target. For years, a